TMO — Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on NYSE. It is led by Marc N. Casper, based in 168 Third Avenue, Waltham, MA, United States, 02451, with about 125,000 employees. Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Latest reported TMO revenue for 2026-03-28 was $11.01B. Net income was $1.65B. Revenue was down 75.3% from 2025-12-31 to 2026-03-28. TMO currently screens at market cap $153.06B and trailing P/E 23.8.

Use this TMO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TMO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TMO SEC filings page. Lician reads the product cache first so this HTML stays unique to Thermo Fisher Scientific Inc even when a live quote feed is slow.